Management of Hepatitis B Virus Infection and Prevention of Hepatitis B Virus Reactivation in Children With Acquired Immunodeficiencies or Undergoing Immune Suppressive, Cytotoxic, or Biological Modifier Therapies
暂无分享,去创建一个
H. Verkade | E. Sokal | F. Smets | B. Fischler | J. Jahnel | M. Abdel-Hady | G. Indolfi | G. Gupte | A. Zellos | S. Bansal | D. Debray | P. Czubkowski | M. Samyn | Y. Mozer‐Glassberg | Wendy J. van der Woerd